Individuals with severe psychiatric illnesses like schizophrenia or mania are at higher risk of adverse effects from psychedelics compared to those with depression or anxiety. — Whalespan
Individuals with severe psychiatric illnesses like schizophrenia or mania are at higher risk of adverse effects from psychedelics compared to those with depression or anxiety.
⚠ High risk
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
◐PARTIALLYSUPPORTED
⚠
High-risk intervention — consult a physician before acting.Drug-drug interactions, dose-dependence, and screening contraindications apply.
“The far more likely danger is the bad trip. Anyone can have this. The most psychologically healthy person in the world probably you jack the dose high enough and especially in in in a less than ideal environment, you can have a bad trip. You you even get it in an ideal environment like ours at at a high dose of around 30 milligrams of psilocybin after you know the best preparation we can provide about a third of people will say essentially at some point they have a bad trip”